MA
DXCM icon

MCF Advisors’s DexCom DXCM Stock Holding History

MCF Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.5K Hold
483
– – ﹤0.01% 777
2026
Q1 		$30.3K Hold
483
– – ﹤0.01% 713
2025
Q4 		$32.1K Buy
+483
New +$31.2K ﹤0.01% 595
2025
Q1 		– Sell
-15
Closed -$1.17K – 937
2024
Q4 		$1.17K Buy
15
+14
+1,400% +$1.04K ﹤0.01% 898
2024
Q3 		$68 Sell
1
-12
-92% -$985 ﹤0.01% 987
2024
Q2 		$1.47K Hold
13
– – ﹤0.01% 873
2024
Q1 		$1.8K Buy
13
+1
+8% +$126 ﹤0.01% 828
2023
Q4 		$1.49K Sell
12
-4
-25% -$409 ﹤0.01% 807
2023
Q3 		$1.49K Hold
16
– – ﹤0.01% 796
2023
Q2 		$2.06K Hold
16
– – ﹤0.01% 709
2023
Q1 		$1.86K Hold
16
– – ﹤0.01% 714
2022
Q4 		$1.81K Buy
16
+4
+33% +$439 ﹤0.01% 690
2022
Q3 		$1K Hold
12
– – ﹤0.01% 733
2022
Q2 		$1K Sell
12
-8
-40% -$730 ﹤0.01% 690
2022
Q1 		$3K Buy
+20
New +$2.19K ﹤0.01% 594
2021
Q4 		– Sell
-20
Closed -$3K – 224
2021
Q3 		$3K Buy
+20
New +$2.52K ﹤0.01% 565

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

MCF Advisors's DXCM Position: Q2 2026 in Review

MCF Advisors held its DexCom (DXCM) position steady in Q2 2026 at 483 shares worth $32.5K. The position accounts for ﹤0.01% of the portfolio, ranked #777.

MCF Advisors first reported a position in DXCM in Q3 2021 and has held it in 16 quarters since. 971 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • MCF Advisors held 483 shares of DexCom worth $32.5K as of Q2 2026.
  • MCF Advisors left its DexCom share count unchanged in Q2 2026.
  • DexCom made up ﹤0.01% of MCF Advisors's portfolio in Q2 2026, its #777 holding.
  • MCF Advisors first reported a position in DexCom in Q3 2021 and has held it in 16 quarters since.
  • 971 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.